Indian generic-drug makers Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. recalled some batches of drugs in the U.S. after separate complaints of bottling mix-ups.
Sun Pharma is recalling a batch of generic diabetes tablets after a customer complained of finding pills of an epilepsy medication mixed in. Separately, rival Ranbaxy pulled two batches of its version of Pfizer Inc.’s Lipitor cholesterol-lowering drug from the U.S. market. Both recalls were listed in the Food and Drug Administration’s enforcement report for the week of March 5.
